Martin De Biasio, Thomas Arnold, Raimund Leitner, Franz G. Wurtz
[1] M. De Biasio, R. Leitner, F. Wuertz, S. Verzakov, andP. J. Elbischger. Enhancement of m-fish Images us-ing Spectral Unmixing. In Proc. of World Congresson Science, Engineering and Technology, volume 34,pages 124–130, October 2008. [2] T. Arnold, R. Leitner, F. G. Wuertz, and P. J. El-bischger. Spot Counting for Automated Analysis ofUnmixed Hyper-Spectral M-fish Images. In Proc. ofWorld Congress on Science, Engineering and Tech-nology, volume 34, pages 124–130, October 2008. [3] N. Harbeck, W. Eiermann, J. Engel, I. Funke,A. Lebeau, W. Parmanetter, and M. Untch. Prognose-faktoren beim primaeren Mammakarzinom, volume 8.Zuckerschwendt, Muenchen, Bern, Wien, New York,2001. [4] D. M. Barnes, J. Bartkova, R.S. Camplejohn, W. J.Gullick, P. J. Smith, P. J. Mills, and R. R. Millis.Overexpression of the c-erbb-2 oncogene: Why doesthis occur more frequently in ductal carcinoma in situthan in invasive mammary carcinoma and is this ofprognostic significance? Eur J Cancer, 28:644–648,1992. [5] E. Liu, A. Thor, M. He, M. Barcos, B. M. Ljung, andC. Benz. The her2 (c-erbb-2) oncogene is frequentlyamplified in in-situ carcinomas of the breast. Onco-gene, 7:1027–1032, 1992. [6] N. E. Hynes and D. F. Stern. The biology of erbb-2/neu/her-2 and its role in cancer. Biochim BiophysActa, 198:165–184, 1994. [7] E. Hyytinen, T. Visakorpi, A. Kallioniemi, O.P.Kallioniemi, and J. Isola. Improved technique foranalysis of formalin-fixed, paraffin-embedded tumorsby fluorescence in situ hybridization. Cytometry,16:93–99, 1994. [8] PathVysion HER-2/neu DNA Probe Kit Package In-sert, Vysis Inc. [9] S. Herzog. Evaluation der HER-2/neu-Genamplifikation an Tumorabklatschpraeparatenvon Mammakarzinomen mittels FISH und derenWertigkeit im Vergleich zur immunhistochemis-chen membranassoziierten Proteinueberexpression.Universitaets-Frauenklinik mit Poliklinik Tuebingen,Allgemeine Geburtshilfe und Frauenheilkunde,Germany, pages 22-25, 2005. [10] F. H. Kaiser. The varimax criterion for analytic ro-tation in factor analysis. Psyhometrika, 23:187–200,1958. [11] M. Forina, C. Armanio, S. Lanteri, and R. Leardi.Methods of varimax rotations in factor analysis withapplications in clinical food chemistry. Journal ofChemometrics, 2:115–125, 1998. [12] F. C. Sanchez, J. Toft, B. van den Bogaert, and D. L.Massart. Orthogonal projection approach applied topeak purity asessment. Anal. Chem., 68:79–85, 1996.
Important Links:
Go Back